Effects of doxorubicin on cardiac contractility, glutathione and ldpid peroxidation

R. H. Kennedv, R. P. Wyeth, E. Seifen, Z. Feng, Y. Cao, Vicki Klimberg

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

It has been proposed that the cardiotoxicity of doxorubicin (DOX) is mediated via oxidative mechanisms. Experiments examined this hypothesis by determining if effects of DOX-treatment on contractility are paralleled by changes in glutathione levels or lipid peroxidation (as monitored via levels of malonyldialdehyde, MDA). Rats were injected with a single dose of 4, 6 or 8 mg/kg DOX (or solvent) 3 or S weeks before tissue isolation. Contractility was monitored in trial (AM) and papillary (PM) muscle that was bathed in Krebs-Henseleit solution (30°C). Glutathione and MDA were monitored in ventricular tissue using standard assays. ' DOXtreatment elicited decreases in rest-potentiated developed tension and the isoproterenol-induced positive inotropic effect in both AM and PM. The force-frequency relationship showed a DOX-associated decrease in basal developed tension in AM at frequencies between 0.1 and 0.5 Hz; however, PM showed no differences in basal developed tension at any frequency from 0.1 to 4.S Hz. Glutathione levels were decreased, while MDA was increased in ventricular myocardium by DOX-treatment. There were no differences in tissues isolated 3 or 5 weeks after injection of DOX. These data support the hypothesis that the cardiomyopathy elicited by DOX is mediated, at least in part, by oxidative damage.

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number3
StatePublished - 1996
Externally publishedYes

Fingerprint

doxorubicin
peroxidation
Doxorubicin
Glutathione
glutathione
Malondialdehyde
Tissue
Papillary Muscles
cardiomyopathy
myocardium
Cardiomyopathies
Isoproterenol
Lipid Peroxidation
Muscle
Rats
Assays
Myocardium
lipid peroxidation
injection
Lipids

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Kennedv, R. H., Wyeth, R. P., Seifen, E., Feng, Z., Cao, Y., & Klimberg, V. (1996). Effects of doxorubicin on cardiac contractility, glutathione and ldpid peroxidation. FASEB Journal, 10(3).

Effects of doxorubicin on cardiac contractility, glutathione and ldpid peroxidation. / Kennedv, R. H.; Wyeth, R. P.; Seifen, E.; Feng, Z.; Cao, Y.; Klimberg, Vicki.

In: FASEB Journal, Vol. 10, No. 3, 1996.

Research output: Contribution to journalArticle

Kennedv, RH, Wyeth, RP, Seifen, E, Feng, Z, Cao, Y & Klimberg, V 1996, 'Effects of doxorubicin on cardiac contractility, glutathione and ldpid peroxidation', FASEB Journal, vol. 10, no. 3.
Kennedv, R. H. ; Wyeth, R. P. ; Seifen, E. ; Feng, Z. ; Cao, Y. ; Klimberg, Vicki. / Effects of doxorubicin on cardiac contractility, glutathione and ldpid peroxidation. In: FASEB Journal. 1996 ; Vol. 10, No. 3.
@article{09859cb2bc9040c5b4447bd3a17d4240,
title = "Effects of doxorubicin on cardiac contractility, glutathione and ldpid peroxidation",
abstract = "It has been proposed that the cardiotoxicity of doxorubicin (DOX) is mediated via oxidative mechanisms. Experiments examined this hypothesis by determining if effects of DOX-treatment on contractility are paralleled by changes in glutathione levels or lipid peroxidation (as monitored via levels of malonyldialdehyde, MDA). Rats were injected with a single dose of 4, 6 or 8 mg/kg DOX (or solvent) 3 or S weeks before tissue isolation. Contractility was monitored in trial (AM) and papillary (PM) muscle that was bathed in Krebs-Henseleit solution (30°C). Glutathione and MDA were monitored in ventricular tissue using standard assays. ' DOXtreatment elicited decreases in rest-potentiated developed tension and the isoproterenol-induced positive inotropic effect in both AM and PM. The force-frequency relationship showed a DOX-associated decrease in basal developed tension in AM at frequencies between 0.1 and 0.5 Hz; however, PM showed no differences in basal developed tension at any frequency from 0.1 to 4.S Hz. Glutathione levels were decreased, while MDA was increased in ventricular myocardium by DOX-treatment. There were no differences in tissues isolated 3 or 5 weeks after injection of DOX. These data support the hypothesis that the cardiomyopathy elicited by DOX is mediated, at least in part, by oxidative damage.",
author = "Kennedv, {R. H.} and Wyeth, {R. P.} and E. Seifen and Z. Feng and Y. Cao and Vicki Klimberg",
year = "1996",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Effects of doxorubicin on cardiac contractility, glutathione and ldpid peroxidation

AU - Kennedv, R. H.

AU - Wyeth, R. P.

AU - Seifen, E.

AU - Feng, Z.

AU - Cao, Y.

AU - Klimberg, Vicki

PY - 1996

Y1 - 1996

N2 - It has been proposed that the cardiotoxicity of doxorubicin (DOX) is mediated via oxidative mechanisms. Experiments examined this hypothesis by determining if effects of DOX-treatment on contractility are paralleled by changes in glutathione levels or lipid peroxidation (as monitored via levels of malonyldialdehyde, MDA). Rats were injected with a single dose of 4, 6 or 8 mg/kg DOX (or solvent) 3 or S weeks before tissue isolation. Contractility was monitored in trial (AM) and papillary (PM) muscle that was bathed in Krebs-Henseleit solution (30°C). Glutathione and MDA were monitored in ventricular tissue using standard assays. ' DOXtreatment elicited decreases in rest-potentiated developed tension and the isoproterenol-induced positive inotropic effect in both AM and PM. The force-frequency relationship showed a DOX-associated decrease in basal developed tension in AM at frequencies between 0.1 and 0.5 Hz; however, PM showed no differences in basal developed tension at any frequency from 0.1 to 4.S Hz. Glutathione levels were decreased, while MDA was increased in ventricular myocardium by DOX-treatment. There were no differences in tissues isolated 3 or 5 weeks after injection of DOX. These data support the hypothesis that the cardiomyopathy elicited by DOX is mediated, at least in part, by oxidative damage.

AB - It has been proposed that the cardiotoxicity of doxorubicin (DOX) is mediated via oxidative mechanisms. Experiments examined this hypothesis by determining if effects of DOX-treatment on contractility are paralleled by changes in glutathione levels or lipid peroxidation (as monitored via levels of malonyldialdehyde, MDA). Rats were injected with a single dose of 4, 6 or 8 mg/kg DOX (or solvent) 3 or S weeks before tissue isolation. Contractility was monitored in trial (AM) and papillary (PM) muscle that was bathed in Krebs-Henseleit solution (30°C). Glutathione and MDA were monitored in ventricular tissue using standard assays. ' DOXtreatment elicited decreases in rest-potentiated developed tension and the isoproterenol-induced positive inotropic effect in both AM and PM. The force-frequency relationship showed a DOX-associated decrease in basal developed tension in AM at frequencies between 0.1 and 0.5 Hz; however, PM showed no differences in basal developed tension at any frequency from 0.1 to 4.S Hz. Glutathione levels were decreased, while MDA was increased in ventricular myocardium by DOX-treatment. There were no differences in tissues isolated 3 or 5 weeks after injection of DOX. These data support the hypothesis that the cardiomyopathy elicited by DOX is mediated, at least in part, by oxidative damage.

UR - http://www.scopus.com/inward/record.url?scp=0242566327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242566327&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0242566327

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -